Future studies that seek to verify these findings in additional cohorts (including APOE genotyped individuals), investigation of heparin dosage and duration responses, and profiling the effects of heparin administration in molecular studies of AD-model systems may offer avenues to advance these findings. This evidence concerns the gene APOE and Alzheimer disease.